Open-i Logo
Submit this form Query By Image

Internet Explorer requires you to use Upload Image button. Other browsers support the ability to drag and drop the image to anywhere in the browser window to perform an Image Search or use the Upload Image button.

Supported File Types are: .jpeg, .jpg, .gif and .png.
Results 81 - 100 of 1170017 Prev 3 4 5 6 7 Next View as List View Image Grid View

- Selected Limits -

Query By Image

Warning: getimagesize(/openi/ssd/prod/wwwroot/current/imgs/rescaled100/f0a0c622 f0a1c105 f0a2c0 f1a0c52 f2a0c81 f2a1c5 f3a0c219 f4a0c256 f4a1c3 f4a2c3.png): failed to open stream: No such file or directory in /openi/ssd/prod/wwwroot/wwwroot-v1.3.1-2013-04-01/leftnav.php on line 61
Similar Results Image

Rank By

Image Type

Subsets

Specialties

Search In
Alignment comparison of amino acid sequences of the E. granulosus antigen B family.Proteins sequences were predicted from the second exons of E. granulosus antigen B shown in Figure 3 and compared with the representative sequences deposited in the GenBank databases. Homologies are assigned with black representing identity in at least six sequences with white representing different nucleotides. Missing or unmatched sequence is hyphenated. Phylogenetic analysis of ten E. granulosus antigen B family.Protein sequences encoded by the second exons of EgAgB genes isolated from a single PSC (ZGP) and MAW (ZGA), and homologues from other Taenia spp. and Hymenolepis diminuta. Sequences from GenBank with accession number were used for the tree analysis. Nucleotide sequence (with protein sequence) data reported in this paper are available in the GenBank, EMBL and DDBJ databases under the accession numbers: GU166196-GU166216 with the same clone name shown in the figure. Bootstrap values (1000 replicates) are shown for each node. Time to fever clearance.Kaplan – Meier survival analysis of time to fever clearance by treatment group (CQ or placebo) and population; A) Intention to treat population and B) Per Protocol population. Three patients afebrile at enrollment developed fever later (1 in the CQ arm and 2 in the Placebo arm) and for the purposes of analysis were considered positive at the time of enrolment. Participant flow in the randomized controlled trial of CQ vs. Placebo. Expression levels of antigen B family in E. granulosus by real-time PCR.Genes representing five antigen B subfamilies (AgB1–5) were amplified using the subfamily specific primers with mRNA isolated from different stages of E. granulosus. PSC, protoscolex; CM, cyst membrane; IAW, immature adult worm; MAW, mature adult worm; ONC, oncosphere; Mix, a pooled sample of all stages. Actin, E. granulosus actin II. E. granulosus eukaryotic translation initiation factor (Eg-eif) was used as a house-keeping gene.
Time to resolution of viraemia.Kaplan – Meier survival analysis of time to resolution of plasma viraemia by treatment group (CQ or placebo) and population; A) Intention to treat population and B) Per Protocol population. Time to negative NS1 antigenaemia.Kaplan – Meier survival analysis of time to resolution of NS1 antigenaemia by treatment group (CQ or placebo) and population; A) Intention to treat population and B) Per Protocol population. Two patients NS1 negative at enrollment were later positive (both in the CQ arm) and for the purposes of analysis were considered positive at the time of enrolment. Surface phenotypes of CD4+ and CD8+ T cells in laboratory-confirmed dengue patients randomized to placebo or CQ.The Box and Whisker plots show the median number and range (2.5–97.5 percentile) of percentages of surface-activated T cells in peripheral blood from CQ (n = 74) and Placebo (n = 73) treated laboratory-confirmed dengue patients at different time points. The median illness day (range) for enrolment samples was 2 (0–3) days, for hospital discharge was 6 (4–8) days and for follow-up was 15.5 (13–30) days. Shown are percentages of peripheral blood CD4+ T cells that were A) CD38+HLA-DR+, B) CD38+Ki67+, and C) Ki67+ HLA-DR+. Also shown are percentages of CD8+ T cells that were, D) CD38+, HLA-DR+, E) CD38+Ki67+, and F) Ki67+ HLA-DR+. The labels below the graphs indicate the time at which sample collection occurred. Heterologous expression and purification of E. histolytica family A DNA polymerase.(A) Coomassie blue stained SDS-PAGE (10%) gel showing the expression and purification of EhDNApolA. Lane1, uninduced pCOLD-EhDNApolA construct; lane 2, IPTG induced sample; lane 3, insoluble fraction; lane 4, soluble lysate; lane 5, nickel agarose flow-through; lane 6, 35 mM imidazol wash; lane 7, 50mM imidazol wash; lane 8, nickel agarose column eluate; lane 9, phosphocelulose column eluate; lane 10, molecular weight standards. (B) Detection of recombinant and endogenous EhDNApolA.Recombinant EhDNApolA and total extracts of E. histolytica were resolved by SDS-PAGE (15%), electroblotted onto nitrocellulose membrane, and immunoblotted with diverse antibodies. Lane 1, recombinant EhDNApolA treated with commercial anti-6 histidines antibody; lane 2, recombinant EhDNApolA treated with mouse antibodies raised against an epitope of EhDNApolA; lane 3, total protein extracts of E. histolytica treated with preimmune serum; lane 4, total protein extracts of E. histolytica treated with specific mouse antibodies raised an epitope of EhDNApolA. Plasma concentrations of pro- and anti-inflammatory cytokines in laboratory-confirmed dengue patients randomized to placebo or CQ.The Box and Whisker plots show the median and range (2.5th–97.5th percentile) of plasma concentrations of A) IL-6, B) IL-8, C) IL-10, D) GM-CSF, E) IFN- γ, and F) TNF-α from DF and DHF patients treated with CQ or Placebo. The dashed line represents the assay limit of detection. Concentrations of IL-2 and IL-4 are not shown because they were below the limit of detection.
Phylogenetic analysis and structural modeling of E. histolytica family A DNA Polymerase.(A) Phylogenetic relationship of family A polymerases from different organisms. ClustalW multiple sequence alignment of diverse DNA polymerases were used to construct a phylogenetic tree using the neighbor joining algorithm present in the MEGA program. GenBank accession numbers of each protein are indicated in Table S2. The significance of each branch of the phylogenetic tree is indicated by a bootstrap percentage (B) Domain organization of EhDNApolA. EhDNApolA lacks the 3′-5′ exonuclease domain present in Klenow fragment. The polymerization domain of EhDNApolA is organized into three subdomains: thumb, palm, and fingers (C) Structural model of EhDNApolA. The N-terminal domain is shown in orange. The polymerization subdomains: thumb, palm, and fingers are colored in green, red, and cyan respectively. The model was constructed using the crystal structure of Klenow Fragment as a template (PDB ID: 1KFS). Biochemical characterization of EhDNApolA.(A) EhDNApolA binds to double stranded DNA. Increasing concentrations of recombinant EhDNApolA (from 0 to 180 nM) were incubated with a fixed amount of double stranded primer-template. The binding of the EhDNApolA to the primer-template is observed by the formation of a slower migrating complex on a native 6% polyacryalmide gel. (B) EhDNApolA is an active DNA polymerase. DNA polymerase activity was measured by the extension of 24mer primer annealed to a 45mer template. Lanes 1 and 4 contained reactions with no added polymerase, EhDNApolA (lanes 2 and 3) or Kf (exo-) (lanes 5 and 6). Reactions in lanes 2 and 5 were incubated with dTTP,dGTP and ddATP. Reactions in lanes 3 and 6 were incubated with all four dNTPs. Incorporation of ddATP results in extension to a 36mer and incubation with all four dNTPs results in a 45mer product. (C) Strand displacement activity of EhDNApolA. Strand displacement was determined using a six-nucleotide substrate gap depicted below Figure3D. The reactions contained 25 units of φ 29 DNA polymerase (lane 2), 4 units of Taq DNA polymerase (lane 3), 5 units of T7 DNA polymerase (lane 4), and 45 fmol of EhDNApolA (lane 5). The 18mer primer can be freely extended to a 24mer. Further extension is only possible if the DNA polymerase displaced the annealed 21mer. Nucleotide insertion fidelity of EhDNApolA.16% denaturing polyacriylamide gel showing a primer-template extension by EhDNApolA in the presence of 100 µM of the indicated nucleotide. The first templated base is denoted with an X as depicted in figures A, B, C, and D. The identity of each dNTP in each reaction is indicated. The 24mer substrates and the 25mer products are indicated by an arrow. (A) Nucleotide fidelity for templated adenine (lanes 1 to 4). (B) Nucleotide fidelity for templated thymine (lanes 5 to 8). (C) Nucleotide fidelity for templated cytidine (lanes 9 to 12). (D) Nucleotide fidelity for templated guanine (lanes 13 to 16). Translesion DNA synthesis by EhDNApolA.16% denaturing polyacrylamide gel electrophoresis showing translesion bypass of EhDNApolA. The first templated base is denoted with an X. The structure of each templated lesion and a templated thymine are depicted for comparison. The reactions were incubated with increased amounts of EhDNApolA (0, 60, 120, and 240 fmol) and 20pM of each substrate. Thymine (lanes 1–4); 8-oxo guanosine (lanes 5–8,); 5 S-6R thymine glycol (lanes 9–12); 5R-6S thymine glycol (lanes 13–16,); cis-syn cyclobutane pyrimidine dimer (lanes 17–20); 6-4 photo product (lanes 21–24); abasic site (lanes 25–29). The bottom arrow indicates the substrate length and the top arrow indicates the expected full-length products. Fidelity of translesion DNA synthesis by EhDNApolA.16% denaturing polyacrylamide gel electrophoresis showing translesion bypass fidelity of EhDNApolA. 0.2 pmol of EhDNApolA were incubated with a set of substrates containing several DNA lesions. The reactions were carried out with four dNTPs or single dNTP addition. (A) 8-oxo guanosine (lanes 1 to 6). (B) abasic site (lanes 1 to 6). (C) 5 S-6R thymine glycol (lanes 1 to 6). (D) 5R-6S thymine glycol (lanes 1 to 6). The identity of each nucleotide is indicated in the figure. The length of the substrates, single nucleotide extensions and full-length products are indicated by arrows.
Map of study sites in Ecuador, Peru, Bolivia, and Paraguay.Capitals of Ecuador (Quito), Peru (Lima), and Bolivia (La Paz) are shown for reference. Cellular identification and localization of EhDNApolA.(A) RT-PCR using total RNA from E. histolytica trophozoites grown in basal culture conditions 1% Agarose gel stained with ethidium bromide showing the RT-PCR products of motifs A (lane 3) and C (lane 4) of the EhDNApolA gene. The RT-PCR product of the actin gene control is shown in lane 2. (B) Immunodetection of EhDNApolA. Western blot assays using, cytoplasmic extracts (lane 1), and nuclear extracts (lane 2) of E. histolytica Monthly distribution of participants with arbovirus infection in Iquitos, Peru, 2000–2007.Data are represented as the percent of participants with date of disease onset in each month. The monthly distribution of all participants is shown in (A), while participants with recent infection by a DENV, an alphavirus, or an orthobunyavirus are shown in (A), (B), and (C), respectively. DENV serotypes circulating in western South America, 2000–2007.DENV serotypes circulation was analyzed based on different regions, including (A) Ecuador and northwestern Peru (Tumbes and Piura), (B) northeastern and central Peru (Iquitos, Yurimaguas, and La Merced), and (C) southeastern Peru (Puerto Maldonado) and Bolivia. The location of study area, Shandong Province in mainland China.
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Department of Health & Human Services
Privacy, Accessibility, Frequently Asked Questions, Contact Us, Collection
Freedom of Information Act, USA.gov